Waddill William D.'s Form 4 filing
Arrowhead Pharmaceuticals, Inc. (ARWR) · filed Dec 23, 2025
- Accession no.
- 0001553338-25-000005
- Filed
- Dec 23, 2025
- Trade date
- Dec 19, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $566.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Waddill William D.CIK 0001553338 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Common Stock | SSaleDisposed | −2,416 | $66.66 | −$161,050.56 | 62,514 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −5,451 | $68.01 | −$370,722.51 | 57,063 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −500 | $68.53 | −$34,265 | 56,563 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.